Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Lymphoma 1 Lung Neoplasms 1 Localized Prostate Cancer 1 Leukemia 1 Laryngeal Diseases 1 Inflammation 1

Interventions

Capecitabine 24 Oxaliplatin 22 Radiotherapy 15 Fluorouracil 13 Surgical Procedures, Operative 11 Drug Therapy 8 Chemoradiotherapy 8 Bevacizumab 8 Leucovorin 7 Consolidation Chemotherapy 7 Radiation 6 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 sintilimab 4 Neoadjuvant Therapy 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3 Cyclophosphamide 3 Cetuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04503694 2025-03-05

REGINA

Jules Bordet Institute

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡